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Introduction
Focal FDG Activity in the Region of Right Atrium: 
Coregistered CT Identifies Three Benign Etiologies 
Murali Meka, M.D., E. Gordon Depuey, M.D., Peeyush Bhargava, M.D.
We present the whole body FDG PET-CT images on 3 different patients with benign focal activity in 
the region of the right atrium. Co-registered CT correctly identified the cause of focal FDG activity as: 
right atrial appendage, lipomatous hypertrophy of the interatrial septum, and catheter-related activ-
ity. Although all these have been reported separately in the literature, we are presenting them together 
to emphasize the importance of recognizing the benign causes of FDG uptake in the region of right 
atrium and the role of co-registered CT in improving the accuracy and specificity of the FDG PET.
We present the whole body FDG PET-CT images on 
three different patients with benign focal activity in the 
region of the right atrium. Although all these have been re-
ported separately in the literature, we are presenting them 
together to emphasize the importance of recognizing the 
benign causes of FDG uptake in the region of right atrium 
and the role of co-registered CT in improving the accuracy 
and specificity of the FDG PET.
Case Report 1
A 66-year-old woman with history of breast cancer 
was evaluated for metastatic disease with PET-CT. Focal 
18F-flurodeoxyglucose (FDG) activity with standard-
ized uptake value (SUV) measuring 2.4 was noted on the 
transaxial images at the interatrial septum, which corre-
lated with a linear area of low attenuation measuring fat 
density (white arrow) (-57 Hounsfield units) on CT scan 
(Fig. 1). The mean cross-sectional thickness of this low 
attenuation region was 10 mm. Based on the CT appear-
ance, a presumptive diagnosis of lipomatous hypertrophy 
of the interatrial septum was made. Lipomatous hypertro-
phy of the interatrial septum is a benign process in which 
the adipose tissue, a normal component of the interatrial 
septum, increases and infiltrates between the myocardial 
fibers (1). FDG uptake in lipomatous hypertrophy of the 
interatrial septum can be explained by the presence of a 
variable amount of brown fat in the interatrial septum (2). 
CT scan is a sensitive imaging modality to diagnose fat 
attenuation in the interatrial septum (3, 4).
Case Report 2
A 54-year-old woman with history of lung cancer, status 
post right upper lobectomy, was evaluated for metastatic 
disease with FDG PET-CT. On the fused PET-CT im-
ages (Fig. 2), focal FDG uptake is seen in the right atrial 
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Figure 1. 66-year-old woman with breast cancer evaluated 
for metastatic disease with PET-CT. Focal FDG activity in the 
interatrial septum on PET corresponded with low attenua-
tion on CT, consistent with lipomatous hypertrophy of the 
interatrial septum.
Figure 2. 54-year-old woman with lung cancer, status post right upper lobectomy, being evaluated for metastatic disease. Fused 
PET-CT images show focal FDG uptake in the right atrial appendage (white arrow), with no anatomic abnormality seen on cor-
responding CT images.
A 68-year-old man with history of colon cancer, was 
evaluated for possible metastatic disease. FDG PET-CT 
showed focal FDG uptake is seen in the right upper medis-
tinum corresponding to the distal end of a central venous 
catheter (white arrow) with an SUV measuring 5.0 (Fig. 
3). Corresponding CT images demonstrated the distal part 
of the catheter at or near the junction of right brachio-
cephalic vein and superior vena cava. Catheter related 
injury can lead to thrombosis (7) and subsequent inflam-
matory response with resultant FDG uptake (8). Both site 
of insertion and distal end of catheters can show increased 
FDG uptake with inflammation (9, 10). Co-registration of 
the CT scan acquired with PET-CT increases the diagnos-
tic accuracy by reducing the number of equivocal lesions 
seen with PET alone (11). It is important to recognize 
appendage (white arrow). No anatomic evidence of mass 
or neoplasm is seen in corresponding CT images. The 
increased FDG activity in the wall of right atrium may 
be associated with atrial fibrillation or could be a normal 
variant (2, 5). The patient has no history of cardiac disease 
or atrial fibrillation. FDG activity could be due to normal 
physiologic uptake in the right auricle or atrial appendage, 
a thick muscular pouch of the superior extremity of the 
right atrium (6).
Case Report 3
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Discussion
Figure 3A. 68-year-old man with colon cancer evaluated for 
metastatic disease. PET-CT images focal FDG uptake is seen 
in the right upper medistinum, corresponding to the distal 
end of a central venous catheter (white arrow).
these benign causes of focal FDG activity when reporting 
the PET scan for evaluation of malignancies.
PET is a powerful diagnostic tool for staging and ther-
apy monitoring of several malignancies. As altered glucose 
metabolism is characteristic of malignant cells in almost all 
cancers, FDG uptake is very sensitive for tumor localiza-
tion. However, increased FDG uptake can also be associ-
ated with normal healthy tissue, infected or inflammatory 
cells, and post-traumatic reparatory processes including 
post surgical granulation tissue. This benign uptake can be 
mistaken for the presence of a malignancy. A co-registered 
CT scan better delineates the anatomy of the equivocal 
lesions which in turn increases the diagnostic accuracy 
and specificity when compared to PET alone (11). This 
case report illustrates the powerful diagnostic ability of the 
combined PET-CT in differentiating the benign variants 
from malignancy.
It is a well-documented that left ventricular myocardial 
uptake of F-18 FDG can be variable. The assumption is 
that the myocardium preferentially uses fatty acids dur-
ing the fasting state and the FDG tracer should not be 
taken up by the myocardium because it is glucose analog. 
However, in the fasting state FDG uptake in the ven-
tricular myocardium is not uncommon since glucose can 
still account for 30-40% of energy derived from oxidative 
metabolism (12). On the other hand, there is no signifi-
cant uptake in a normal atrium, as its energy expenditure 
is minimal when compared to the ventricles (13). There 
is no clear documentation in the literature regarding the 
FDG uptake in the region of right atrium. We believe 
that it is very important to point out the different non-
malignant causes of the FDG uptake in the region of right 
atrium, since it can be potentially mistaken for an underly-
ing cardiac or extra-cardiac malignancy. In this case report, 
we present three patients with known malignancies who 
underwent PET scan as a part of their evaluation. The 
PET images demonstrated FDG uptake in the superior 
mediastinum and middle mediastinum in the region of 
the right atrium, while the corresponding CT images 
revealed catheter related injury, lipomatous hypertrophy 
of interatrial septum, and a normal right atrial append-
age. The other likely benign causes for an increased uptake 
in the right atrium are atrial fibrillation, congestive heart 
failure with valvular disease, and atrial septal defect (5). 
However, none of the patients described in this case report 
had documented history of cardiac disease. Alternatively, 
as discussed, the increased mediastinal uptake in the 
region of right atrium can also be caused by primary and 
secondary malignancies involving the heart, lung and the 
mediastinum. Therefore, in the evaluation of chest by PET 
scan, we suggest that the interpreting physicians consider 
all the benign causes for FDG uptake in the region of right 
atrium, and additionally obtain a corresponding CT image 
to better characterize the lesion. This helps to minimize the 
rate of false positive diagnoses and resultant unwarranted 
treatments.
We conclude that a co-registered CT image of the chest, 
along with familiarity of the benign causes for atrial FDG 
uptake, increases the diagnostic specificity and accuracy of 
F-18 FDG PET. 
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